Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy
Authors
Keywords
Advanced non-small cell lung cancer, APE1, ERCC1, Individualized chemotherapy, TUBB3
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 74, Issue 4, Pages 777-786
Publisher
Springer Nature
Online
2014-08-08
DOI
10.1007/s00280-014-2562-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ERCC1 expression correlated with EGFR and clinicopathological variables in patients with non‐small cell lung cancer. An immunocytochemical study on fine‐needle aspiration biopsies samples
- (2014) A. Kalogeraki et al. Revista Portuguesa de Pneumologia
- Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer
- (2013) Gerold Bepler et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
- (2012) W. E. Pierceall et al. ANNALS OF ONCOLOGY
- Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy
- (2012) Xue-Feng Leng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy
- (2012) E. M. McNeil et al. NUCLEIC ACIDS RESEARCH
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic Role of ERCC1 in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2011) Joshua A. Roth et al. Clinical Lung Cancer
- The Expression of ERCC1, RRM1, and BRCA1 in Breast Cancer According to the Immunohistochemical Phenotypes
- (2011) Dokyung Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC
- (2011) A. Vilmar et al. LUNG CANCER
- Prognostic significance of APE1 cytoplasmic localization in human epithelial ovarian cancer
- (2011) Qingsong Sheng et al. MEDICAL ONCOLOGY
- Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers
- (2010) A Al-Attar et al. BRITISH JOURNAL OF CANCER
- Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment
- (2010) Gianluca Tell et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Downregulation of XPF–ERCC1 enhances cisplatin efficacy in cancer cells☆
- (2010) Sanjeevani Arora et al. DNA REPAIR
- Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of III-Tubulin
- (2010) P. P. Gan et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
- (2009) Dong Wang et al. LUNG CANCER
- Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
- (2009) Rafael Rosell et al. PLoS One
- Understanding DNA Damage Response and DNA Repair Pathways: Applications to More Targeted Cancer Therapeutics
- (2009) Timothy J. Kinsella SEMINARS IN ONCOLOGY
- ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
- (2008) Lifeng Wang et al. BMC CANCER
- Predictive Markers of Tubulin-Targeting Agents in Breast Cancer
- (2008) Shou-Ching Tang Clinical Breast Cancer
- Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
- (2008) Pascal Sève et al. LANCET ONCOLOGY
- Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
- (2008) Koichi Azuma et al. LUNG CANCER
- A new APE1/Ref-1-dependent pathway leading to reduction of NF- B and AP-1, and activation of their DNA-binding activity
- (2008) K. Ando et al. NUCLEIC ACIDS RESEARCH
- ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer
- (2007) Tetsuya Fujii et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now